Keyphrases
Heart Failure
65%
Patients with Heart Failure
32%
Myocardial Infarction
24%
Left Ventricular Ejection Fraction
21%
ST-elevation Myocardial Infarction (STEMI)
18%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
18%
Heart Failure with Preserved Ejection Fraction (HFpEF)
18%
Heart Failure Patients
17%
Chronic Heart Failure
17%
All-cause Mortality
15%
Acute Heart Failure
14%
Prognostic Value
13%
Confidence Interval
12%
Risk Stratification
11%
Hazard Ratio
11%
Cardiovascular Mortality
9%
Epicardial Adipose Tissue
9%
Soluble Suppression of Tumorigenicity 2 (sST2)
9%
Body Mass Index
8%
Heart Failure Hospitalization
8%
Cardiac Regeneration
8%
High-sensitivity Troponin T
7%
Neprilysin
7%
Cardiovascular Disease
6%
Myocardium
6%
Cardiac Function
6%
Cardiogenic Shock
6%
Adipocyte Progenitor Cells
6%
Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs)
6%
Estimated Glomerular Filtration Rate
6%
Cell Therapy
5%
Atrial Fibrillation
5%
Extracellular Vesicles
5%
Natriuretic Peptides
5%
Multivariable
5%
Quality of Life
5%
European Society of Cardiology
5%
Ambulatory Heart Failure
5%
Sacubitril-valsartan
5%
Infarct Size
5%
Acute Myocardial Infarction
5%
Composite Endpoint
5%
Mortality Prediction
5%
Medicine and Dentistry
Congestive Heart Failure
85%
Myocardial Infarction
22%
Heart Left Ventricle Ejection Fraction
18%
Biological Marker
18%
Adipose Tissue
15%
Cardiovascular System
14%
ST Segment Elevation Myocardial Infarction
12%
Ejection Fraction
11%
Mesenchymal Stem Cell
9%
Myocardium
9%
Risk Stratification
9%
Progenitor Cell
9%
Infarction
9%
Acute Decompensated Heart Failure
8%
Amino Terminal Sequence
8%
Hazard Ratio
8%
Diseases
8%
Heart Failure with Preserved Ejection Fraction
8%
Cardiovascular Disease
8%
Dilated Cardiomyopathy
7%
Brain Natriuretic Peptide
7%
Cardiogenic Shock
7%
Heart Failure with Reduced Ejection Fraction
7%
Cord Blood
7%
Cell Therapy
6%
Cardiology
6%
Cardiac Magnetic Resonance Imaging
6%
Heart Ventricle Remodeling
6%
Outpatient
6%
Interatrial Block
5%
Heart Function
5%
Acute Heart Infarction
5%
Body Mass Index
5%
Atrial Fibrillation
5%
Heart Muscle Ischemia
5%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Heart Infarction
26%
Biological Marker
25%
ST Segment Elevation Myocardial Infarction
13%
Brain Natriuretic Peptide
12%
Infarction
10%
Acute Heart Failure
10%
Troponin T
9%
Membrane Metalloendopeptidase
9%
All Cause Mortality
9%
Heart Failure with Reduced Ejection Fraction
7%
Clinical Trial
7%
Heart Ventricle Remodeling
7%
Non Insulin Dependent Diabetes Mellitus
6%
Acute Heart Infarction
6%
Cardiovascular Disease
6%
Valsartan/Sacubitril
5%
Cause of Death
5%
Inflammation
5%
Pig
5%
Disease
5%
